Bleeding Associated with Warfarin Therapy
At a Glance Approximately 3 million Americans are on vitamin K antagonist therapy (VKA) for a variety of clinical conditions, including thrombophilia, cardiac conditions, and stroke. Warfarin is a VKA that interferes with recycling of vitamin K (VK) in hepatocytes by inhibiting mainly epoxide reductase (see chapter on VK deficiency). The therapeutic INR of 2-3.5…